Nestin expression involves invasiveness of esophageal carcinoma and its downregulation enhances paclitaxel sensitivity to esophageal carcinoma cell apoptosis

Paclitaxel has been generally used to treat primary and metastatic esophageal carcinoma. It has been shown that nestin is highly expressed in esophageal carcinoma and that there is a strong association of nestin expression with poor prognosis in esophageal carcinoma patients. In this study, using im...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jinghang, Zhong, Jiateng, Yu, Jian, Li, Jinsong, Di, Wenyu, Lu, Ping, Yang, Xiaoyu, Zhao, Weixing, Wang, Xianwei, Su, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630311/
https://www.ncbi.nlm.nih.gov/pubmed/29029411
http://dx.doi.org/10.18632/oncotarget.17774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630311/
https://www.ncbi.nlm.nih.gov/pubmed/29029411
http://dx.doi.org/10.18632/oncotarget.17774

Ejemplares similares